Clinical Remissions In Three Otherwise Intractable Cancers Signal The ...
Epeius Biotechnologies Corporation announced more stunning results of its pioneering clinical studies of Rexin-G, the world's first and, so far only, tumor-targeted genetic medicine to be validated in the clinic.
Join the discussion below, or Read more at MediLexicon.
#1 Oct 14, 2009
This agent has orphan drug status via the FDA as well as Fast Track Designation in a number of solid tumors, so it is probably not without some credibility.
I wonder why on earth is there nothing in the prostate cancer literature or web sites about it?
#2 Sep 23, 2013
I have ordered 2 times from this website PILLSMEDSHOP. COM . I called yesterday the customer care and asked for a discount as i was about to order twice the regular amount.
Add your comments below
|MALAT1 is a driver for metastasis||Oct 20||Kirkits||1|
|Yale Expert Speaks on Metastatic Breast Cancer ...||Oct 17||Stephany McDowell||1|
|Breast cancer diagnosis: When to seek a second ...||Oct 8||Javk||1|
|Identical Twins Diagnosed With Same Rare Cancer...||Sep 27||Stephany McDowell||1|
|Microsoft wants to 'solve cancer' with computer...||Sep '16||Stephany McDowell||2|
|Cancer-risk genetic testing reports can vary fr...||Sep '16||Stephany McDowell||1|
|Retired Ringling Bros. circus elephants have a ...||Sep '16||Stephany McDowell||1|
Find what you want!
Search Oncology Forum Now
Copyright © 2016 Topix LLC